Round Heart Disease (poultry)

Round heart disease is a significant cardiovascular condition primarily affecting commercial turkeys and, to a lesser extent, broiler chickens, characterized by progressive dilation of both ventricles resulting in a distinctive rounded appearance of the heart when viewed in cross-section or from the apex. This condition represents a form of dilated cardiomyopathy in which the heart muscle weakens and loses its ability to contract effectively, leading to decreased cardiac output, congestive heart failure, and ultimately death in affected birds. The rounded configuration of the heart results from biventricular dilation replacing the normal more angular or triangular shape of the healthy avian heart.

Round heart disease primarily affects rapidly growing commercial turkey poults and young turkeys, with peak incidence typically occurring between two and sixteen weeks of age. The condition has been recognized in turkey production for decades and continues to cause economically significant losses in commercial operations despite efforts at genetic selection and management modifications. While less commonly reported in broiler chickens, similar dilated cardiomyopathy conditions have been described in fast-growing broiler strains, suggesting shared pathophysiological mechanisms related to the cardiovascular stress of rapid growth.

The economic and welfare impact of round heart disease encompasses direct mortality losses, which can range from less than one percent to several percent of a flock depending on genetic susceptibility and environmental conditions. Affected birds experience progressive exercise intolerance, respiratory distress, and suffering before death, raising significant welfare concerns. The unpredictable nature of losses and the lack of effective treatment options make round heart disease a frustrating condition for producers. Condemnation of affected carcasses at processing adds to economic losses when subclinically affected birds survive to market age.

Early detection and implementation of preventive management strategies offer the best approach to reducing losses from round heart disease, as treatment of clinically affected individuals is generally ineffective and economically impractical. The strong genetic component of susceptibility means that selection programs can significantly reduce flock risk over time. Understanding the interaction between genetics, nutrition, environmental conditions, and management practices is essential for developing comprehensive prevention programs that minimize the impact of this challenging cardiovascular condition.

The primary cause of round heart disease appears to be a fundamental weakness or defect in cardiac muscle that leads to progressive dilation and loss of contractile function. Unlike pulmonary hypertension syndrome where pressure overload drives right ventricular changes, round heart disease involves primary myocardial failure affecting both ventricles without necessarily increased resistance to blood flow. The exact cellular and molecular mechanisms underlying this myocardial weakness remain incompletely understood, though research suggests involvement of abnormalities in calcium handling, sarcomere structure, or myocardial energy metabolism that impair the heart's ability to generate normal contractile force.

Genetic predisposition plays a central role in susceptibility to round heart disease, with strong heritability demonstrated in turkey breeding studies. Certain genetic lines exhibit markedly higher incidence rates than others, and selection against the condition has proven effective in reducing flock prevalence over time. The genetics of susceptibility appear to involve multiple genes affecting cardiac development, function, and response to stress. Male birds are more commonly and more severely affected than females, possibly due to their faster growth rates and larger body size creating greater cardiovascular demands. The strong genetic component makes careful attention to source genetics an important management consideration.

Environmental and management factors influence the expression of round heart disease in genetically susceptible populations. Rapid early growth appears to increase the stress on developing cardiovascular systems and may trigger disease onset in predisposed birds. Feed restriction programs that moderate growth rate have been associated with reduced incidence in some studies. Environmental stressors including temperature extremes, poor ventilation, and handling stress may precipitate cardiovascular decompensation in birds with subclinical disease. Altitude effects, while less pronounced than in pulmonary hypertension syndrome, may contribute to increased incidence at higher elevations.

Risk factors for round heart disease include young age during the rapid growth phase, male sex, certain genetic backgrounds, and management conditions that promote maximum growth rate. The period of highest susceptibility typically coincides with the phase of most rapid body weight gain when cardiovascular demands are increasing rapidly. Birds maintained at high stocking densities or under other stressful conditions may experience higher incidence. Nutritional factors including vitamin and mineral deficiencies, particularly those affecting cardiac function such as selenium and vitamin E, may exacerbate susceptibility in predisposed birds.

The disease mechanism in round heart disease involves progressive ventricular dilation as the weakened myocardium stretches under normal blood volumes and pressures. As dilation progresses, the geometric relationship between muscle fibers and chamber volume becomes increasingly inefficient, further reducing contractile effectiveness in a self-perpetuating cycle. Eventually, the dilated ventricles cannot generate sufficient cardiac output to meet metabolic demands, leading to congestive heart failure with fluid accumulation, exercise intolerance, and death. The biventricular nature of the dilation distinguishes round heart disease from pure right-sided failure seen in pulmonary hypertension syndrome.

Early warning signs of round heart disease are often subtle and may be overlooked without careful flock observation. Affected birds may demonstrate slightly reduced activity levels compared to flockmates, spending more time resting and showing less interest in feed and water. Mild exercise intolerance may manifest as birds that are slow to move away from approaching personnel or that fatigue quickly when the flock is disturbed. Growth rate in individual birds developing round heart disease may be normal or even above average early in the disease process, making early identification based on growth performance unreliable.

As the condition progresses, affected turkeys and broilers display increasingly obvious signs of cardiovascular compromise. Exercise intolerance becomes pronounced, with birds reluctant to walk or stand for extended periods and showing rapid fatigue and respiratory distress with minimal exertion. Affected birds may be observed sitting frequently with wings slightly elevated from the body and necks extended, postures that facilitate breathing when cardiovascular function is compromised. Cyanosis of the snood, caruncles, and skin in turkeys or the comb and wattles in chickens develops as oxygen delivery to peripheral tissues becomes inadequate.

Behavioral changes associated with round heart disease include depression, reduced feed and water consumption, and separation from the flock. Affected birds often position themselves at the periphery of the group or in corners where they are less likely to be disturbed by flock activity. The characteristic appearance of a sick bird with ruffled feathers, drooping head, and reluctance to move becomes evident. Social interactions decrease, and birds may show reduced response to stimuli that would normally elicit reaction. Feed conversion efficiency deteriorates as affected birds expend energy on increased respiratory effort while consuming less feed.

Physical signs of round heart disease include the development of fluid accumulation characteristic of congestive heart failure. Ascites, the accumulation of fluid in the abdominal cavity, may develop as right-sided heart failure leads to systemic venous congestion. Subcutaneous edema may be palpable, particularly in the ventral body wall and pericloacal region. The jugular veins may appear distended due to elevated central venous pressure. Hepatomegaly can sometimes be appreciated on palpation in thin birds as the liver enlarges due to chronic passive congestion.

Symptom progression in round heart disease typically occurs over days to weeks, though the timeline varies considerably between individuals and depends on the severity of underlying cardiac dysfunction. Birds may appear relatively normal until cardiovascular compensation fails, at which point clinical decline can be rapid. The progression from subtle exercise intolerance to obvious congestive heart failure may occur gradually or suddenly, particularly if environmental stressors precipitate acute decompensation in a marginally compensated bird.

Emergency symptoms requiring immediate recognition include severe respiratory distress with open-mouth breathing and gasping, extreme lethargy with inability or reluctance to stand, marked cyanosis of visible tissues, and impending collapse. Sudden death may occur without previously observed clinical signs, particularly following exertion or stress. Finding multiple dead birds of similar age without prior illness should prompt suspicion of round heart disease or other cardiovascular conditions. Mortality patterns may show clustering within certain genetic families or lines if genetics is a strong contributing factor.

Clinical examination of birds suspected of having round heart disease focuses on identifying signs of congestive heart failure and ruling out other potential causes of similar symptoms. Cardiac auscultation may reveal abnormal heart sounds including murmurs associated with valvular insufficiency secondary to chamber dilation, or muffled heart sounds if pericardial effusion is present. Jugular vein distension and prolonged jugular refill time indicate elevated central venous pressure. Abdominal palpation may detect ascites or hepatomegaly. General condition assessment including hydration status, muscle condition, and respiratory character provides additional diagnostic information.

Diagnostic testing for round heart disease relies heavily on post-mortem examination of freshly dead or euthanized affected birds. The characteristic finding at necropsy is the rounded, globoid appearance of the heart due to biventricular dilation. The heart often appears enlarged relative to body size, with thin, flaccid ventricular walls that have lost normal muscular tone. The right ventricle to total ventricle weight ratio may be increased, though not to the same degree as in pure right-sided failure from pulmonary hypertension. Passive hepatic congestion with an enlarged, mottled liver is typically present. Ascites and pericardial effusion are common findings.

Differential diagnosis for round heart disease includes other causes of cardiac failure and sudden death in poultry. Pulmonary hypertension syndrome causes primarily right-sided failure and can usually be differentiated by the presence of right ventricular hypertrophy and signs of pulmonary vascular disease. Furazolidone toxicity causes dilated cardiomyopathy with round heart appearance but has become rare since the drug was banned from food animal use. Ionophore toxicity can cause cardiac muscle damage with similar gross appearance. Nutritional deficiencies, particularly selenium and vitamin E, cause myocardial degeneration that may present similarly. Bacterial pericarditis should be ruled out through examination for purulent material.

Herd-level diagnostics for round heart disease include monitoring mortality patterns, conducting systematic necropsy surveillance, and tracking the incidence of cardiac conditions among mortality causes. Mortality analysis may reveal peaks during the rapid growth phase characteristic of round heart disease timing. Necropsy of representative mortality samples allows quantification of round heart disease contribution to total losses. Genetic tracking may identify particular family lines or source flocks with elevated susceptibility. Environmental and management records help identify correlations between conditions and disease incidence that might guide prevention efforts.

Emergency treatment options for individual birds with clinical round heart disease are extremely limited due to the fundamental nature of the cardiac muscle dysfunction. Unlike human dilated cardiomyopathy where medications can improve cardiac function and quality of life, pharmacological options for poultry are constrained by lack of approved drugs, impracticality of individual bird treatment, and food safety regulations for meat birds. Affected birds with obvious clinical signs should be humanely euthanized to prevent further suffering, as recovery from established dilated cardiomyopathy is not expected. Providing a quiet, stress-free environment may prolong survival in mild cases but does not address the underlying disease.

Medical management of round heart disease in poultry is not practically feasible in commercial production settings. Cardiac medications used in other species such as positive inotropes, diuretics, and ACE inhibitors are not approved for use in food-producing poultry and would be impractical to administer to individual birds in a flock setting. Even if treatment were attempted, withdrawal time concerns would preclude marketing treated birds for human consumption. Research into pharmaceutical interventions has not identified effective treatments that would be practical for field use. The focus of management must remain on prevention rather than treatment.

Surgical treatment has no role in management of round heart disease, as the diffuse myocardial weakness cannot be corrected surgically and cardiac surgery is not feasible in poultry. Pericardiocentesis might provide temporary relief in birds with significant pericardial effusion, but fluid reaccumulates rapidly and the procedure does not address the underlying cardiac dysfunction. The impracticality and lack of efficacy of surgical approaches reinforces the importance of preventive measures and genetic selection for reducing round heart disease incidence.

Supportive care for flocks experiencing round heart disease mortality focuses on reducing cardiovascular stress through management modifications. Reducing environmental temperature to the lower end of the thermoneutral zone decreases metabolic oxygen demand. Minimizing handling, transport, and other stressors reduces cardiovascular workload. Ensuring excellent ventilation optimizes oxygen availability and removes respiratory irritants. Decreasing lighting intensity and duration may help reduce activity and feed intake, slowing growth rate. These measures may reduce progression of subclinical disease to clinical failure but will not reverse established cardiac damage.

Herd treatment protocols for round heart disease center on growth rate moderation and stress reduction strategies. Feed restriction programs that limit daily intake or implement meal feeding slow growth rate and reduce cardiovascular demands during the susceptible period. Reducing dietary energy density achieves similar growth moderation while allowing ad libitum access to feed. Some research suggests that specific amino acid modifications may reduce cardiac stress, though practical applications remain limited. Ensuring adequate vitamin E and selenium nutrition supports cardiac muscle function and may have protective effects in borderline cases.

Treatment decisions must balance the welfare implications of maintaining affected birds in the flock against economic and practical considerations. Birds with obvious clinical signs should be culled promptly to prevent suffering and remove potentially infectious or genetically susceptible individuals from the population. Economic analysis should consider the costs of management interventions, expected reduction in mortality, effects on growth performance, and the genetic value of the flock. In breeding flocks, identification and removal of genetic families with high round heart disease incidence improves the population for future generations.

Recovery from clinical round heart disease is not expected once birds develop significant ventricular dilation and congestive heart failure, as the myocardial changes are irreversible with currently available approaches. The dilated, thinned ventricular walls cannot regenerate normal muscle mass or function, and compensatory mechanisms eventually fail as the disease progresses. Birds that appear to recover from acute episodes typically have only partial resolution of congestion while retaining underlying cardiac dysfunction that makes them susceptible to future decompensation. True reversal of dilated cardiomyopathy has not been demonstrated in poultry.

Post-treatment care and monitoring in flocks where management interventions have been implemented to reduce round heart disease incidence involves tracking mortality rates and causes to assess intervention effectiveness. Daily mortality counts should be analyzed for trends indicating improvement or continued problems. Continued necropsy surveillance provides information about whether the proportion of mortality due to round heart disease is changing. Growth performance monitoring helps determine whether feed restriction or other growth-moderating interventions are having the intended effect while maintaining acceptable production parameters.

Prognosis for birds with clinical round heart disease is poor, with death typically occurring within days to weeks of developing obvious clinical signs. The timeline depends on the severity of cardiac dysfunction and the presence of environmental stressors that might accelerate decompensation. Birds identified early in the disease process through careful observation might survive longer if protected from stress, but recovery is not expected. At the flock level, prognosis for reducing mortality depends on the ability to moderate growth rate, reduce stressors, and in the longer term, improve genetic resistance through selection.

Return to production considerations are largely theoretical for round heart disease survivors, as clinical recovery is uncommon. Birds that experience subclinical cardiac stress without progressing to overt failure may reach market weight but often show reduced growth efficiency and may be at increased risk of death from handling stress during catching and transport. Meat quality might be affected in birds that experienced significant cardiovascular compromise. In breeding populations, birds from families with high round heart disease incidence should not be retained for breeding purposes regardless of individual apparent health status, as the genetic component of susceptibility makes them unsuitable breeding stock.

Vaccination plays no direct role in prevention of round heart disease since the condition is not caused by infectious agents. However, maintaining overall flock health through appropriate vaccination programs indirectly supports cardiovascular health by reducing stress from infectious disease challenges. Respiratory infections that compromise oxygen exchange or systemic infections that increase metabolic demands may trigger decompensation in birds with borderline cardiac function. Comprehensive vaccination programs designed in consultation with poultry veterinarians help maintain the overall health status that supports cardiovascular resilience.

Biosecurity measures contribute to round heart disease prevention by maintaining optimal flock health and reducing disease challenges that stress the cardiovascular system. Excellent sanitation and hygiene reduce pathogen exposure that might trigger inflammatory responses or septicemia adding to cardiac workload. Controlling environmental conditions including temperature stability, air quality, and moisture management reduces physiological stress. All-in-all-out production with thorough cleaning and disinfection between flocks eliminates potential carryover of pathogens and provides fresh start conditions for each placement.

Nutritional prevention strategies focus on supporting cardiac muscle health and moderating growth rate to reduce cardiovascular stress. Ensuring adequate vitamin E and selenium levels is essential, as these nutrients support myocardial function and protect against oxidative damage. Some research suggests potential benefits from specific amino acid supplementation, though practical recommendations remain limited. Feed restriction programs that slow early growth rate reduce cardiovascular demands during the critical susceptibility period. Lower-energy diets achieve similar growth moderation while allowing continuous feed access. Avoiding nutritional excesses that promote maximum growth rate helps protect genetically susceptible birds.

Management practices for round heart disease prevention emphasize reduction of cardiovascular stressors and moderation of growth rate. Temperature management maintaining birds in the lower portion of their thermoneutral zone reduces metabolic oxygen demand without causing cold stress. Excellent ventilation ensures adequate oxygen availability and removes ammonia and other air quality challenges. Reduced lighting intensity and duration limits activity and may help moderate growth rate. Lower stocking densities reduce competition stress and improve air quality. Minimizing handling and disturbance reduces acute cardiovascular stress that might trigger decompensation in susceptible birds.

Genetic selection represents the most powerful long-term tool for preventing round heart disease. Breeding companies have made significant progress in reducing susceptibility through selection programs that identify and eliminate susceptible genetic lines. Producers should work with suppliers to obtain poults or chicks from breeding programs that actively select against round heart disease. Tracking mortality by source flock allows identification of suppliers with elevated round heart disease incidence. Within breeding operations, rigorous culling of affected families and selection pressure against the condition progressively improves population resistance over generations.

Daily management and monitoring for round heart disease prevention requires consistent attention to flock behavior, mortality patterns, and environmental conditions. Regular walk-throughs should include observation for birds showing reduced activity, respiratory distress, or failure to compete normally at feeders and waterers. Prompt removal of affected birds through humane euthanasia improves flock welfare and provides necropsy material for ongoing surveillance. Daily mortality counts tracked and analyzed for trends help identify emerging problems before losses become severe. Feed and water consumption monitoring provides early warning of changes in flock health status.

Housing and environmental management play critical roles in reducing cardiovascular stress that contributes to round heart disease expression. Ventilation systems must maintain excellent air quality while providing adequate oxygen exchange and controlling temperature and humidity. Temperature management should target the lower end of the comfort range to minimize metabolic demands without causing cold stress. Stocking density should allow adequate space for movement and access to resources without crowding stress. Lighting programs should include adequate dark periods for rest. Flooring and bedding management affects air quality through dust and ammonia control.

Herd health programs for turkey operations or broiler flocks with round heart disease concerns should include regular veterinary consultation, systematic necropsy surveillance, and data analysis to guide management decisions. Veterinarians can help identify risk factors specific to individual operations and design customized prevention programs. Routine necropsy of mortality samples quantifies round heart disease contribution to total losses and monitors trends over time. Performance data analysis helps identify correlations between management factors and cardiovascular mortality that might guide intervention strategies.

Record keeping and monitoring systems should capture mortality by cause based on necropsy findings, environmental parameters, nutritional program details, genetic source information, and growth performance data. This information enables identification of factors associated with elevated or reduced round heart disease incidence and evaluation of intervention effectiveness. Computerized monitoring systems facilitate data collection and analysis for ventilation, temperature, and other environmental parameters. Production records should be maintained in formats that allow retrospective analysis and benchmarking against industry standards.

Economic considerations for round heart disease management include direct mortality losses, reduced growth performance associated with prevention programs, costs of environmental control and monitoring systems, and the value of improved genetics. Feed restriction programs that successfully reduce round heart disease mortality typically also reduce growth rate, extending production cycles and potentially increasing total costs. Analysis should weigh these costs against mortality savings to determine optimal intervention intensity. Premium pricing for genetics selected for reduced susceptibility may be justified by improved survival and performance. Long-term genetic improvement through breeding programs offers the most sustainable path to reduced economic losses.

High-risk breeds and genetic lines for round heart disease include rapidly growing commercial turkey strains, particularly those selected for maximum growth rate and breast meat yield. Male turkeys are substantially more susceptible than females due to faster growth rates and larger body sizes creating greater cardiovascular demands. Certain genetic lines demonstrate markedly higher incidence rates than others, and the strong heritability of susceptibility makes genetic background a major risk factor. Commercial broiler chickens selected for rapid growth may experience similar dilated cardiomyopathy conditions, though the specific relationship to turkey round heart disease is not fully characterized.

Production type considerations influence round heart disease risk based on growth rate and management intensity. Commercial meat turkey production with emphasis on rapid growth to heavy market weights carries the highest risk. Turkey breeding stock operations face lower risk because birds are typically maintained at controlled weights to optimize reproductive performance, inadvertently reducing cardiovascular stress. Heritage turkey breeds with slower growth rates experience minimal round heart disease. Similarly, slower-growing broiler strains used in specialty production have lower susceptibility than fast-growing commercial strains. Layer chickens are rarely affected due to their different genetic background and slower growth.

Genetic selection and testing for reduced round heart disease susceptibility has proven effective in reducing flock incidence over time. Breeding companies monitor round heart disease incidence in test flocks and selection candidates, eliminating affected families from the breeding population. Selection indices may include cardiac measurements or echocardiographic parameters that predict susceptibility before clinical disease develops. Producers should work with breeding company representatives to select strains with demonstrated resistance to round heart disease, particularly for operations that have experienced elevated losses. The steady reduction in round heart disease incidence in commercial turkey strains over recent decades demonstrates the effectiveness of genetic selection programs when consistently applied.

Commonly co-occurring conditions with round heart disease include other cardiovascular and metabolic conditions affecting rapidly growing poultry. Sudden death syndrome, characterized by acute cardiovascular collapse without preceding illness, may occur in the same flocks experiencing round heart disease losses and likely shares some predisposing factors. Aortic rupture in turkeys, another cardiovascular condition associated with rapid growth and cardiovascular stress, may occur concurrently. Skeletal abnormalities including tibial dyschondroplasia and valgus-varus deformities often affect the same rapidly growing populations susceptible to cardiovascular disease. Secondary bacterial infections may develop in debilitated birds with compromised circulation.

Conditions with similar symptoms that must be differentiated from round heart disease include other causes of congestive heart failure and sudden death in poultry. Pulmonary hypertension syndrome causes primarily right-sided failure with right ventricular hypertrophy rather than the biventricular dilation seen in round heart disease. Spontaneous cardiomyopathy of turkeys, if considered a separate entity, may show similar gross lesions. Ionophore toxicity causes acute myocardial damage that can mimic round heart disease at necropsy, making feed history important for differentiation. Furazolidone toxicity historically caused similar lesions but is now rare. Bacterial pericarditis presents with similar clinical signs but shows characteristic purulent effusion at necropsy.

Complications and sequelae of round heart disease include the secondary effects of congestive heart failure on other organ systems. Chronic passive hepatic congestion leads to liver enlargement and potentially liver failure with coagulation abnormalities. Ascites from right-sided failure may become secondarily infected with bacteria ascending from the gastrointestinal tract. Pulmonary edema and pleural effusion from left-sided involvement compromise respiratory function. Birds that survive with subclinical disease may show reduced growth efficiency and increased susceptibility to other stressors. Muscle hypoxia from reduced cardiac output may affect meat quality in birds that reach processing. The cardiovascular compromise makes affected birds more likely to die from the stress of catching, transport, or other management procedures.